Rivastigmine for ECT-induced cognitive adverse effects in late life depression (RECALL study): A multicenter, randomized, double blind, placebo-controlled, cross-over trial in patients with depression aged 55 years or older: Rationale, objectives and methodsMarieke Henstra, Didi Rhebergen, Pascal Sienaert et al.|Frontiers in Psychiatry|2022Cited by 6
Confusional States During Electroconvulsive Therapy for Late‐Life Depression: A Prospective Cohort StudyThomas C. Feenstra, Didi Rhebergen, Nathalie Denayer et al.|Acta Psychiatrica Scandinavica|2025Cited by 3
The Cortisol Awakening Response as a Biomarker for Cognitive Side-Effects of Electroconvulsive TherapyThomas C. Feenstra, Didi Rhebergen, Eldon K.J. la Cruz et al.|American Journal of Geriatric Psychiatry|2023Cited by 0
Author response for "Confusional States During Electroconvulsive Therapy for Late‐Life Depression: A Prospective Cohort Study"Thomas C. Feenstra, Didi Rhebergen, Nathalie Denayer et al.|Unknown|2025Cited by 0
Author response for "Confusional States During Electroconvulsive Therapy for Late‐Life Depression: A Prospective Cohort Study"Thomas C. Feenstra, Didi Rhebergen, Nathalie Denayer et al.|Unknown|2025Cited by 0